NOVONIX (NVX) director discloses 195,938 share rights holding

Rhea-AI Filing Summary

NOVONIX Ltd director Ronald C. Edmonds reported his holdings of share rights linked to the company’s ordinary shares. The filing shows share rights over 195,938 underlying ordinary shares with an exercise price of $0.00 per share, exercisable from December 31, 2026 and expiring on December 31, 2027. This entry reflects a reported position rather than a new purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Edmonds Ronald C

Role null

Type	Security	Shares	Price	Value
holding	Share rights	--	--	--

Holdings After Transaction: Share rights — 195,938 shares (Direct, null)

Footnotes (1)

Key Figures

Underlying ordinary shares: 195,938 shares Exercise price: $0.00 per share Exercise date: December 31, 2026 +2 more

5 metrics

Underlying ordinary shares 195,938 shares Underlying shares linked to reported share rights

Exercise price $0.00 per share Exercise price for the share rights

Exercise date December 31, 2026 Initial exercise date for share rights

Expiration date December 31, 2027 Expiration of share rights

Total derivative holdings 195,938 underlying shares Derivative position held directly after reported entry

Key Terms

Share rights, Ordinary shares, Exercise price

3 terms

Share rights financial

"security_title: "Share rights" linked to ordinary shares"

Ordinary shares financial

"underlying_security_title: "Ordinary shares" for the derivative"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Exercise price financial

"conversion_or_exercise_price: "0.0000" as the exercise price"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Edmonds Ronald C

(Last) (First) (Middle)

1029 WEST 19TH STREET

(Street)

CHATTANOOGA TENNESSEE 37408

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NOVONIX Ltd [ NVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share rights	$0							12/31/2026	12/31/2027	Ordinary shares	195,938		195,938	D

Explanation of Responses:

	Suzanne Yeates	05/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What does the NOVONIX (NVX) Form 4 filing by Ronald C. Edmonds show?

The Form 4 shows director Ronald C. Edmonds reporting holdings of share rights over 195,938 NOVONIX ordinary shares. These derivative rights have a zero exercise price and defined exercise and expiration dates, but the filing does not reflect a new buy or sell transaction.

How many NOVONIX (NVX) shares are linked to Edmonds’ reported share rights?

The reported share rights are linked to 195,938 underlying NOVONIX ordinary shares. This figure represents the number of ordinary shares that could be issued upon exercise of the share rights, according to the terms disclosed in the filing’s derivative position table.

What are the exercise and expiration dates of the NOVONIX (NVX) share rights?

The share rights reported by Ronald C. Edmonds become exercisable on December 31, 2026. They are scheduled to expire on December 31, 2027, giving roughly one year between the initial exercise date and the final expiration date stated in the filing.

What is the exercise price of the NOVONIX (NVX) share rights reported in this Form 4?

The Form 4 lists an exercise price of $0.00 per share for the reported share rights. This means no cash payment would be required to convert the share rights into NOVONIX ordinary shares under the terms summarized in the filing.

Does the NOVONIX (NVX) Form 4 indicate that Edmonds bought or sold shares?

The Form 4 characterizes the entry as a holding of share rights with an unknown transaction code. The transaction summary shows no buy or sell shares recorded, indicating this filing primarily updates or reports an existing derivative position rather than documenting a new trade.